REVOLUTION Medicines(RVMDW)
REDWOOD CITY, CABiotechnology
Focus: REVOLUTION Medicines is a public biotech company focused on small-molecule oncology therapeutics across multiple tumor types including lung cancer, pancreatic cancer, and colorectal cancer. The company operates at clinical-stage with a diversified pipeline spanning Phase 1 through Phase 3 programs.
Profile data last refreshed 3h ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Total Funding
$1B
Open Jobs
260+481 this month
Hot — 589 jobs added in 30d
Net +481 (589 new, 108 removed). Aggressive expansion phase.
Should You Work at REVOLUTION Medicines?
AI assessmentHigh-risk, high-reward opportunity for oncology specialists willing to bet on multiple late-stage programs, but cash runway and pre-commercialization maturity demand careful assessment.
Why Work Here
- Active hiring across 184 open roles with strong commercial and manufacturing expansion signaling confidence in pipeline advancement.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$12M
Pipeline & Clinical Trials
PHASE_1
Clinical Trials (1)
NCT06040541Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Phase 1Help build intelligence for REVOLUTION Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.